Enteric fever, a systemic illness primarily caused by Salmonella Typhi and Paratyphi, remains a significant public health issue globally. This article aims to provide an updated approach to the diagnosis and management of enteric fever, focusing on recent developments and current best practices.
Diagnosis of enteric fever is challenging due to its nonspecific symptoms and the limitations of current diagnostic tests. Blood culture remains the gold standard for diagnosis, but its sensitivity is diminished in the early stages of the disease. Recent advances include the development of molecular diagnostic techniques such as PCR and the use of serological tests like Typhidot and Tubex TF. However, these tests still have limitations in terms of sensitivity and specificity, and further research is needed to validate their use in clinical practice.
The management of enteric fever has been complicated by the increasing prevalence of antibiotic resistance. Current guidelines recommend the use of fluoroquinolones as the first-line treatment, but resistance to these agents is increasing. Therefore, alternative antibiotics such as azithromycin and third-generation cephalosporins are now being recommended. Vaccination also plays a crucial role in the prevention of enteric fever, particularly in endemic areas. However, the currently available vaccines have limitations and there is a need for the development of more effective vaccines.
In conclusion, the diagnosis and management of enteric fever pose significant challenges due to nonspecific symptoms, limitations of diagnostic tests, and increasing antibiotic resistance. It is crucial for healthcare professionals to stay updated on the latest developments in this field to ensure the effective management of patients with enteric fever. Future research should focus on the development of more sensitive and specific diagnostic tests and more effective vaccines.
1.
For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.
2.
FDA Advisors Recommend Galleri Multicancer Blood Test
3.
Women who miss their first mammogram face higher risk of breast cancer death, study finds
4.
Thriving while surviving: Understanding the social needs of cancer survivors
5.
Can Accelerated Salvage RT Improve Prostate Cancer Control?
1.
Fatigue and Work Participation in Blood Disease: A Comprehensive Review
2.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
3.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
4.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
5.
Childhood Cancer Prevention Through Modifiable Exposure Reduction
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Hematologic Fatigue and Work Function: Clinical Implications, Pathophysiology, and Management
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation